FrancophonIA/ELRC3.0 huggingface dataset:
English: For GIST and metastatic renal cell carcinoma, Sutent is given in six-week cycles, at a dose of 50 mg once a day for four weeks, followed by a two-week ‘rest period'.
Swedish: Vid GIST och metastaserad njurcellscancer ges Sutent i sexveckorscykler med en dos på 50 mg en gång dagligen i fyra veckor, följt av två veckors uppehåll.
English: Sutent was also compared with another cancer medicine, interferon alfa, in 750 patients with metastatic renal cell carcinoma whose cancer had not been treated before.
Swedish: Sutent jämfördes också med ett annat läkemedel mot cancer, interferon alfa, på 750 patienter med metastaserad njurcellscancer som inte hade behandlats tidigare.
English: What is the risk associated with Sutent?
Swedish: Vilka är riskerna med Sutent?
English: • gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel where there is uncontrolled growth of cells in the supporting tissues of these organs.
Swedish: • Gastrointestinal stromacellstumör (GIST), en cancerform i mage och tarm som orsakar okontrollerad celltillväxt i stödvävnaderna i dessa organ.
English: The most serious side effects reported with Sutent include heart and kidney failure, pulmonary embolism (clot in a blood vessel supplying the lungs), gastrointestinal perforation (holes in the wall of the gut), and internal haemorrhages (bleeding).
Swedish: De allvarligaste biverkningarna som rapporterats för Sutent är hjärt- och njursvikt, lungembolism (en blodpropp i lungan), gastrointestinala perforationer (hål i tarmväggen) och inre blödningar.
English: Sutent was compared with placebo (a dummy treatment) in 312 patients with GIST whose previous treatment with imatinib had failed and in 171 patients with worsening pancreatic neuroendocrine tumours that could not be removed with surgery.
Swedish: Sutent jämfördes med placebo (overksam behandling) på 312 patienter med GIST där behandlingen med imatinib hade misslyckats och på 171 patienter med pankreatiska neuroendokrina tumörceller som förvärrades och som inte kunde avlägsnas genom operation.
English: Why has Sutent been approved?
Swedish: Varför godkänns Sutent?
English: What is Sutent used for?
Swedish: Vad används Sutent för?
English: In metastatic renal cell carcinoma, patients taking Sutent lived for an average of 47.3 weeks without their disease worsening, compared with 22.0 weeks in the patients receiving interferon alfa.
Swedish: Vid metastaserad njurcellscancer levde patienter som fick Sutent i genomsnitt 47,3 veckor utan att sjukdomen förvärrades, jämfört med 22,0 veckor för patienter som fick interferon alfa.
English: • metastatic renal cell carcinoma, a type of kidney cancer, that has spread to other parts of the body;
Swedish: • Metastaserad njurcellscancer, en form av njurcancer som har spritt sig till andra delar av kroppen.
English: For more information about treatment with Sutent, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Swedish: Mer information om behandling med Sutent finns i bipacksedeln (ingår också i EPAR).
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sutent, including the appropriate precautions to be followed by healthcare professionals and patients.
Swedish: I enlighet med denna plan har säkerhetsinformation tagits med i produktresumén och bipacksedeln för Sutent.
English: These enzymes can be found in some receptors at the surface of cancer cells, where they are involved in the growth and spread of cancer cells and in the blood vessels that supply the tumours, where they are involved in the development of new blood vessels.
Swedish: Dessa enzymer kan påträffas i vissa receptorer på cancercellernas yta där de medverkar till cancercellernas tillväxt och spridning.
English: The dose can be adjusted according to the patient's response to the treatment, but should be kept within the range of 25 to 75 mg. For pancreatic neuroendocrine tumours, Sutent is given at a dose of 37.5 mg once a day without a rest period.
Swedish: Dosen kan justeras beroende på patientens svar på behandlingen, men den ska hållas inom intervallet 25 mg till 75 mg.
English: How is Sutent used?
Swedish: Hur används Sutent?
English: How has Sutent been studied?
Swedish: Hur har Sutents effekt undersökts?
English: Sutent was originally given ‘conditional approval' because there was more evidence to come about the medicine, in particular in the treatment of renal cell carcinoma.
Swedish: Detta innebär att det skulle komma fler uppgifter om läkemedlet, särskilt gällande behandlingen av njurcellscancer.
English: (Invented) name Strength Pharmaceutical Form
Swedish: (Läkemedlets) namn Styrka Läkemedelsform Administrerings sätt
English: EU number
Swedish: MTnr
English: 83607 Holzkirchen Germany
Swedish: 25, 83607 Holzkirchen Tyskland
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF SANOHEX AND ASSOCIATED NAMES (SEE ANNEX I)
Swedish: ÖVERGRIPANDE SAMMANFATTNING AV DEN VETENSKAPLIGA UTVÄRDERINGEN AV SANOHEX OCH SYNONYMER (SE BILAGA I)
English: Inhalation use
Swedish: Användning för inhalation
English: 100 μg/dose
Swedish: 100 µg/dos
English: Pressurised inhalation, suspension
Swedish: Inhalationsspray, suspension
English: The marketing applications were submitted as hybrid applications under Article 10(3) of Directive 2001/83/EC and the EU reference product is Sultanol Dosier-Aerosol 100 μg/dose, Druckgasinhalation, suspension, (GlaxoSmithKline).
Swedish: Ansökningarna om försäljningstillstånd har lämnats in som blandade ansökningar i enlighet med artikel 10.3 i direktiv 2001/83/EG och EU:s referensprodukt är Sultanol Dosier-Aerosol 100 μg/dos, Druckgasinhalation, suspension, (GlaxoSmithKline).
English: Sanohex is a metered dose aerosol inhaler containing a suspension formulation of salbutamol sulphate 100 µg/spray, with HFA 134a as propellant.
Swedish: Sanohex är en inhalationsaerosol som innehåller en suspension av salbutamolsulfat 100 µg/spray, med HFA 134a som drivgas.
English: The Applicant also decided to generate additional spacer data in order to obtain more reliable information on the particle size distribution when the compared inhalers are fitted with their respective spacer devices.
Swedish: Sökanden bestämde sig också för att skapa kompletterande uppgifter om andningsbehållaren för att få mer tillförlitlig information om fördelningen av partikelstorlekar när de jämförda inhalatorerna monteras med sina respektive andningsbehållare.
English: the CHMP has recommended the granting of the Marketing Authorisations for which the valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure are set out in Annex III for Sanohex and associated names (see Annex I).
Swedish: CHMP förordar beviljande av det godkännande för försäljning för vilket den gällande produktresumén, märkningen och bipacksedeln är de slutgiltiga versioner som uppnåtts under samordningsgruppens förfarande såsom fastställs i bilaga III för Sanohex och synonymer (se bilaga I) av följande skäl:
English: - the CHMP considered that Sanohex and the reference product possess the same systemic safety profile, as demonstrated by the bioequivalence in systemic levels (AUC and Cmax),
Swedish: - CHMP ansåg att Sanohex och referensprodukten har samma systemiska säkerhetsprofil, såsom påvisas av bioekvivalens på systemiska nivåer (AUC och Cmax).
English: The pharmacokinetic bioequivalence data also confirmed that Sanohex and the reference product possess the same systemic safety profile since bioequivalence in systemic levels (AUC and Cmax) have been shown, when used with or without a spacer.
Swedish: De farmakokinetiska bioekvivalensuppgifterna bekräftade dessutom att Sanohex och referensprodukten har samma systemiska säkerhetsprofil eftersom bioekvivalens har påvisats i systemiska nivåer (AUC och Cmax), vid användning med eller utan andningsbehållare.
English: Member State /EU/EEA
Swedish: Medlemsstat EU/EES
English: 1138, Budapest
Swedish: 1138, Budapest Ungern
English: County Mayo Ireland
Swedish: County Mayo Irland
English: Kruczkowskiego 8 st., 00-380 Warszawa Poland
Swedish: Kruczkowskiego 8 st., 00-380 Warszawa, Polen
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Swedish: Förteckning över läkemedlets namn, läkemedelsform, styrkor, administreringssätt av läkemedlet samt innehavare av godkännande för försäljning i medlemsstaterna
English: D-85716 Unterschleißheim Germany
Swedish: D-85716 Unterschleißheim Tyskland
English: 164 94 Kista
Swedish: 164 94 Kista Sverige
English: Sweden Baxter Medical AB Box 63
Swedish: Baxter Medical AB Box 63
English: Baxter AS Gjerdrumsvei 11 0484 Oslo Norway
Swedish: Baxter AS Gjerdrumsvei 11 0484 Oslo Norge
English: Sodium Hydroxide 52.25 g Water for Injections to 100 ml
Swedish: Natriumhydroxid 52.25 g Vatten för injektionsvätskor till 100 ml
English: Germany Baxter Deutschland GmbH Edisonstr.
Swedish: Tyskland Baxter Deutschland GmbH Edisonstr.
English: Denmark Baxter A/S, Gydevang 43, DK-3450 Allerød
Swedish: Danmark Baxter A/S, Gydevang 43, DK-3450 Allerød
English: Baxter SPA piazzale dell' industria 20 - 00144 Roma, Italy
Swedish: Piazzale dell'Industria 20 00144 Roma Italien
English: Romania BAXTER d.o.o.
Swedish: Rumänien BAXTER d.o.o.
English: Baxter MédicoFarmacêutica, Lda.
Swedish: Baxter Médico Farmacêutica Lda
English: Hungary Baxter Hungary Kft. Népfürdő u. 22.
Swedish: Baxter Ungern Kft. Népfürdö u. 22.
English: L-Tyrosine Ph.Eur.
Swedish: L-tyrosin Ph.Eur.
English: Belgium Baxter SA Boulevard R. Branquart 80 7680 Lessines Belgium
Swedish: Boulevard R. Branquart 80 7680 Lessines Belgien
English: Avenue louis Pasteur ZA de Coignières Maurepas 78310 Maurepas France
Swedish: Frankrike Baxter S.A.S Avenue louis Pasteur 78310 ZA de Coignieres 78310 Maurepas Frankrike
English: 11 g/l amino acids and 1,25 mmol/l Ca.
Swedish: 11 g/l aminosyror och 1,25 mmol/l Ca.
English: Luxembourg Baxter SA, Bd René Branquart 80, B-7860 Lessines Belgium
Swedish: Luxemburg Baxter S.A. Bd René Branquart 80 B-7860 Lessines Belgien
English: Glucose Monohydrate Ph. Eur.
Swedish: Glukosmonohydrat Ph. Eur.
English: 46394 Ribarroja del Turia (Valencia)
Swedish: Ribarroja del Turia (Valencia) 46394 Spanien
English: Pouet de Camilo 2 Ribarroja del Turia (Valencia)
Swedish: Ribarroja del Turia (Valencia)
English: Glucose Monohydrate Ph. Eur.1.1, Sodium Chloride Ph. Eur.
Swedish: Glukosmonohydrat Ph. Eur.1.1, Natriumklorid Ph. Eur.
English: 4.480 g, Sodium chloride Ph. Eur.
Swedish: 4.480 g, natriumklorid Ph. Eur.
English: Icodextrin 7.5 % w/v, Sodium Chloride Ph.
Swedish: Icodextrin 7.5 % w/v, natriumklorid Ph. Eur.
English: Zelezna cesta 14, SI-1000 Ljubljana
Swedish: Zelezna cesta 14, SI-1000 Ljubljana, Slovenien
English: Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeistof
Swedish: Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeis t of
English: Baxter Oy Valimotie 15 A 00381 Helsinki Finland
Swedish: Valimotie 15A 00381 Helsinki Finland
English: Baxter Healthcare GmbH, Stella-Klein-Löw-Weg 15, A-1020 Wien Austria
Swedish: Österrike Baxter Healthcare GmbH, Stella-Klein-Löw-Weg 15, A-1020 Wien
English: BAXTER S.L.
Swedish: Baxter S.A.
English: Zona Industrial da Abrunheira - Edifício 10Sintra Business Park, 2710-089 Sintra Portugal
Swedish: Edificio 10 Sintra Business Park,
English: 0.714 g L-Arginine Ph.Eur.
Swedish: 0.714 g L-arginin Ph.Eur.
English: Natriumklorid Baxter 9 mg/ml solution for infusion intravenous use
Swedish: Natriumklorid Baxter 9 mg/ml
English: 1.1, Sodium Chloride Ph. Eur.
Swedish: 1.1, Natriumklorid Ph. Eur.
English: 0.152, Sodium Lactate Ph. Eur.
Swedish: 0.152, Natriumlaktat Ph. Eur.
English: Netherlands Baxter B.V., Kobaltweg 49, 3542 CE Utrecht
Swedish: Nederländerna Baxter B.V Kobaltweg 49
English: 75.00 g/l Icodextrine
Swedish: 75.00 g/l Icodextrin
English: 3.36, Potassium Chloride Ph. Eur.
Swedish: 3.36, Kaliumklorid Ph. Eur.
English: solution for haemodialysis, haemodiafiltration and haemofiltration intraarterial use, intravenous use, hemodialysis
Swedish: hemodialys-, hemodiafiltrationsoch hemofiltrationsvätsk a intraarteriell användning, intravenös användning, hemodialys
English: 0.646 g, L-Serine Ph.Eur.
Swedish: 0.646 g, L-serin Ph.Eur.
English: 0.54 % w/v, Sodium (S)-lactate 0.45 % w/v, Calcium Chloride Ph. Eur.
Swedish: 0.54 % w/v, natrium (S)laktat 0.45 % w/v, kalciumklorid Ph. Eur.
English: 7,5 % 75 g / 1000 ml peritoneal use
Swedish: 7,5 % 75 g / 1000 ml
English: Anhydrous Glucose Ph.Eur.
Swedish: Glukos anhydrat Ph.Eur.
English: 0.257, Magnesium Chloride Hexahydrate Ph. Eur.
Swedish: 0.257, Magnesiumkloridhexahydrat Ph. Eur.
English: 1.020 g, LLysine hydrochloride Ph.Eur.
Swedish: 1.020 g, Llysinhydroklorid Ph.Eur.
English: 0.184 g, Magnesium chloride hexahydrate Ph.Eur.
Swedish: 0.184 g, magnesiumkloridhexahydrat Ph.Eur.
English: 0.850 g, L-Isoleucine Ph.Eur.
Swedish: 0.850 g, L-isoleucin Ph.Eur.
English: 75 g/l icodextrine
Swedish: 75 g/l icodextrin
English: Box 270 Valimotie 15A 00381
Swedish: Baxter Oy P.O. Box 270 Valimotie 15A 00381 Helsinki Finland
English: 6.43, Calcium Chloride Dihydrate Ph.
Swedish: 6.43, Kalciumkloriddihydrat Ph.
English: 0.0257 % w/v, Magnesium Chloride Ph. Eur.
Swedish: 0.0257 % w/v, magnesiumklorid Ph. Eur.
English: 1.071 g, Calcium chloride dihydrate Ph.Eur.
Swedish: 1.071 g, kalciumkloriddihydrat Ph.Eur.
English: Extraneal (Icodextrin 7.5%) Solution for peritoneal dialysis icodextrin 75g/l; sodium chloride 5.4g/l; calcium chloride 0,257g/l; magnesium chloride 0.051g/l; sodium s-lactate 4.5g/l
Swedish: Extraneal (lcodextrin 7.5%) Solution for peritoneal dialysis icodextrin 75g/l; natriumklorid 5.4g/l; kalciumklorid 0,257g/l; magnesiumklorid 0.051g/l; natrium s-laktat 4.5g/l
English: 0.951 g, L-Valine Ph.Eur.
Swedish: 0.951 g, L-valin Ph.Eur.
English: 0.595 g, Glycine Ph.Eur.
Swedish: 0.595 g, glycin Ph.Eur.
English: 0.850 g, L-Leucine Ph.Eur.
Swedish: 0.850 g, L-leucin Ph.Eur.
English: 1,1% amino acid
Swedish: 1,1% aminosyror
English: Slovenia Baxter d.o.o., Zelezna cesta 18 , Ljubljana, SI-1000, Slovenia
Swedish: Slovenien Baxter d.o.o., Zelezna cesta 18 ,Ljubljana, SI-1000, Slovenien
English: 0.39 % w/v Calcium Chloride Ph.Eur.
Swedish: 0.39 % w/v Kalciumklorid Ph.Eur.
English: 0.0184 % w/v Magnesium Chloride Ph.Eur.
Swedish: 0.0184 % w/v Magnesiumklorid Ph.Eur.
English: 0.955 g, LHistidine Ph.Eur.
Swedish: 0.955 g, Lhistidin Ph.Eur.
English: Kifissias Avenue 368, Halandri, 152 33 Greece
Swedish: Halandri 15233
English: 6.43, Calcium Chloride Dihydrate Ph. Eur.
Swedish: 6.43, Kalciumkloriddihydrat Ph. Eur.
English: Nutrineal PD4 with 1.1% Amino Acids tyrosine 0.03%w/v; tryptophan 0.027%w/v; phenylalanine 0.057%w/v; threonine 0.064%w/v; L-serine 0.051%w/v; L-proline 0.058%w/v; glycine 0.051%w/v; L-alanine 0.095%w/v; valine 0.139%w/v; methionine 0.085%w/v; isoleucine 0.085%w/v; leucine 0.102%w/v; lysine 0.095%w/v; histidine 0/071%w/v; arginine 0.107%w/v; calcium chloride 0.018%w/v; magnesium chloride 0.005%w/v; sodium chloride 0.538%w/v; sodium s-lactate 0.448%w/v
Swedish: Nutrineal PD4 with 1.1% Amino Acids tyrosin 0.03%w/v; tryptofan 0.027%w/v; fenylalanin 0.057%w/v; treonin 0.064%w/v; Lserin 0.051%w/v; L-prolin 0.058%w/v; glycin 0.051%w/v; Lalanin 0.095%w/v; valin 0.139%w/v; metionin 0.085%w/v; isoleucin 0.085%w/v; leucin 0.102%w/v; lysin 0.095%w/v; histidin 0/071%w/v; arginin 0.107%w/v; kalciumklorid 0.018%w/v; magnesiumklorid 0.005%w/v; natriumklorid 0.538%w/v; natrium s-laktat 0.448%w/v
English: Norfolk IP24 3SE United Kingdom
Swedish: Thetford, Norfolk, IP24 3SE Storbritannien
English: 3.86 % w/v or Glucose Monohydrate Ph.Eur.
Swedish: 3.86 % w/v eller glukos monohydrat Ph.Eur.
English: 0.510 g, L-Proline Ph.Eur.
Swedish: 0.510 g, L-prolin Ph.Eur.
English: 2.27 % w/v or Glucose Monohydrate Ph.Eur.
Swedish: 2.27 % w/v eller glukos monohydrat Ph.Eur.
English: 0.448 % w/v Calcium Chloride Ph.Eur.
Swedish: 0.448 % w/v Kalciumklorid Ph.Eur.
English: 75 mg/ml Icodextrin; 5,4 mg/ml Sodium Chloride; 4,5 mg/ml Sodium (S) - lactate solution; 0,051 mg/ml Magnesium Chloride; 0,257 mg/ml Calcium Chloride
Swedish: 75 mg/ml icodextrin, 5,4 mg/ml natriumklorid, 4,5 mg/ml natrium (S) - laktatlösning, 0,051 mg/ml magnesiumklorid, 0,257 mg/ml kalciumklorid
English: 1.36 % w/v or Glucose Monohydrate Ph.Eur.
Swedish: 1.36 % w/v eller glukos monohydrat Ph.Eur.
English: Icodextrin (75 g/l), Sodium chloride (5.4 g/l), Calcium chloride (0.257 g/l), Magnesium chloride (0.051 g/l), Sodium lactate solution (4.5 g/l)
Swedish: Icodextrin (75 g/l), natriumklorid (5.4 g/l), kalciumklorid (0.257 g/l), magnesiumklorid (0.051 g/l), natriumlaktatlösning (4.5 g/l)
English: 0.0257 % w/v Magnesium Chloride Ph.Eur.
Swedish: 0.0257 % w/v Magnesiumklorid Ph.Eur.
English: 0.270 g, L-Phenylalanine Ph.Eur.
Swedish: 0.270 g, Lfenylalanin Ph.Eur.
English: BAXTER d.o.o.,Zelezna cesta 18, 1000 Ljubljana Slovenia
Swedish: Bulgarien BAXTER d.o.o.,Zelezna cesta 18, 1000 Ljubljana, Slovenien
English: 0.538 % w/v Sodium Lactate Ph.Eur.
Swedish: 0.538 % w/v Natriumlaktat Ph.Eur.
English: 3,86% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
Swedish: 3,86% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v Peritonealdialysvätsk a
English: Baxter Healthcare S.A. Moneen Road Castlebar, Co. Mayo Ireland
Swedish: Baxter Healthcare S.A. Moneen Road Castlebar, CO. Mayo lreland
English: Sweden Baxter Healthare SA Moneen Road
Swedish: Baxter Healthare SA Moneen Road Castlebar
English: 1,36% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
Swedish: 1,36% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v Peritonealdialysvätsk a
English: Lithuania Baxter Oy, P.O.
Swedish: Lettland Baxter Oy P.O. Box 270
English: 0.051 g, Sodium-lactate Ph.Eur.
Swedish: 0.051 g, natriumlaktat Ph.Eur.
English: Baxter Healthcare SA Moneen Rd Castlebar, Co. Mayo Ireland
Swedish: Slovakien Baxter Healthcare SA, Moneen Rd, Castlebar, Co. Mayo, Irland
English: Pouet de Camilo 2
Swedish: Spanien Baxter S.L Pouet de Camilo, 2
English: 1.393 g, LMethionine Ph.Eur.
Swedish: 1.393 g, L-metionin Ph.Eur.
English: 1.36% W/V 2,27% W/V 3,86% W/V
Swedish: 2.27% w/v 3.86% w/v
English: Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alanine 951 mg/L, arginine 1071 mg/L, glycine 510 mg/L, histidine 714 mg/L, isoleucine 850 mg/L, leucine 1020 mg/L, lysine hydrochloride 955 mg/L, methionine 850 mg/L, phenylalanine 570 mg/L, proline 595 mg/L, serine 510 mg/L, threonine 646 mg/L, tryptophan 270 mg/L, tyrosine 300 mg/L, valine 1393 mg/L, sodium chloride 5380 mg/L, calcium chloride dihydrate 184 mg/L, magnesium chloride hexahydrate 51 mg/L, sodium(s)-lactate 4480 mg/L
Swedish: Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alanin 951 mg/L, arginin 1071 mg/L, glycin 510 mg/L, histidin 714 mg/L, isoleucin 850 mg/L, leucin 1020 mg/L, Iysin hydroklorid 955 mg/L, metionin 850 mg/L, fenylalanin 570 mg/L, prolin 595 mg/L, serin 510 mg/L, treonin 646 mg/L, tryptofan 270 mg/L, tyrosin 300 mg/L, valin 1393 mg/L, natriumklorid 5380 mg/L, kalciumklorid dihydrat 184 mg/L, magnesiumklorid hexahydrat 51 mg/L, natrium(s)-laktat 4480 mg/L
English: Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24 3SE, UK
Swedish: Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24 3SE, Storbritannien
English: 1,071 mg/ml Arginine; 0,714 mg/ml Histine; 0,955 mg/ml Lysine hydrochloride; 1,02 mg/ml Leucine; 0,85 mg/ml Isoleucine; 0,85 mg/ml Methionine; 1,393 mg/ml Valine; 0,951 mg/ml Alanine; 0,51 mg/ml Glycine; 0,595 mg/ml Proline; 0,51 mg/ml Serine; 0,646 mg/ml Threonine; 0,57 mg/ml Phenylalanine; 0,27 mg/ml Tryptophan; 0,3 mg/ml Tyrosine; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 5,38 mg/ml Sodium Chloride; 4,48 mg/ml Sodium Lactate
Swedish: 1,071 mg/ml arginin, 0,714 mg/ml histin, 0,955 mg/ml lysinhydroklorid, 1,02 mg/ml leucin, 0,85 mg/ml isoleucin, 0,85 mg/ml metionin, 1,393 mg/ml valin, 0,951 mg/ml alanin, 0,51 mg/ml glycin, 0,595 mg/ml prolin, 0,51 mg/ml serin, 0,646 mg/ml treonin, 0,57 mg/ml fenylalanin, 0,27 mg/ml tryptofan, 0,3 mg/ml tyrosin, 0,184 mg/ml kalciumkloriddihydrat, 0,051 mg/ml magnesiumkloridhexahydrat, 5,38 mg/ml natriumklorid, 4,48 mg/ml natriumlaktat
English: Eur., 0.257, Magnesium Chloride Hexahydrate Ph. Eur.0.152, Sodium Lactate Ph. Eur.
Swedish: Magnesiumkloridhexahydrat Ph. Eur.0.152, Natriumlaktat Ph. Eur.
English: Sodium Chloride 5.38 g/l Quantitative Composition of Sodium Lactate Lactic Acid 139 g
Swedish: Natriumlaktat 4.48 g/l Natriumklorid 5.38 g/l Kvantitativ sammansättning av natriumlaktat
English: Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24 3SE United Kingdom
Swedish: Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk, IP24 3SE Storbritannien
English: 0.57 % w/v Sodium Lactate Ph.Eur.
Swedish: 0.57 % w/v Natriumlaktat Ph.Eur.
English: Calcium Chloride: 0.026% w/v. glucose 0.110%w/v; sodium lactate 0.336%w/v; sodium chloride 0.643%w/v; magnesium chloride 0.015%w/v solution for haemodialysis/hae mofiltration intraarterial use, intravenous use
Swedish: Monosol kalciumklorid: 0.026% w/v. glukos 0.110%w/v; natriumlaktat 0.336%w/v; natriumklorid 0.643%w/v; magnesium klorid 0.015%w/v
English: 1.1 g / l 6.43 g / l 0.257 g / l 0.149 g / l 0.152 g / l 3.36 g / l solution for haemodialysis hemodialysis
Swedish: 1.1 g / l 6.43 g / l 0.257 g / l 0.149 g / l 0.152 g / l 3.36 g / l hemodialysvätska hemodialys
English: L-Methionine 0.850 g/l L-Isoleucine 0.850 g/l L-Leucine 1.020 g/l L-Lysine (chlorhydrate) 0.955 g/l L-Histidine 0.714 g/l L-Arginine 1.071 g/l Calcium chloride dihydrate 0.184 g/l Magnesium chloride hexahydrate 0.051 g/l Sodium Lactate 4.48 g/l
Swedish: L-tyrosin 0.300 g/l L-tryptofan 0.270 g/l L-fenylalanin 0.570 g/l L-treonin 0.646 g/l L-serin 0.510 g/l L-prolin 0.595 g/l Glycin 0.510 g/l L-alanin 0.951 g/l L-valin 1.393 g/l L-metionin 0.850 g/l L-isoleucin 0.850 g/l L-leucin 1.020 g/l L-lysin (klorhydrat) 0.955 g/l L-histidin 0.714 g/l L-arginin 1.071 g/l Kalciumkloriddihydrat 0.184 g/l Magnesiumkloridhexahydrat 0.051 g/l
English: 0.300 g, L-Tryptophan Ph.Eur.
Swedish: 0.300 g, Ltryptofan Ph.Eur.
English: 1.1 g / l 6.43 g / l 0.257 g / l 0.298 g / l 0.152 g / l 3.36 g / l solution for haemodialysis hemodialysis
Swedish: 1.1 g / l 6.43 g / l 0.257 g / l 0.298 g / l 0.152 g / l 3.36 g / l hemodialysvätska hemodialys
English: 0.510 g, L-Alanine Ph.Eur.
Swedish: 0.510 g, Lalanin Ph.Eur.
English: 1.1 g / l 6.43 g / l 0.257 g / l 0.152 g / l 3.36 g / l solution for haemodialysis hemodialysis
Swedish: 1.1 g / l 6.43 g / l 0.257 g / l 0.152 g / l 3.36 g / l hemodialysvätska hemodialys
English: Baxter Healthcare Ltd., Caxton Way, Thetford,
Swedish: Slovakien Baxter Healthcare Ltd Caxton Way,
English: Dianeal PD1 Glucose 2.27% w/v /22.7mg/ml sodium chloride 0.57%w/v; glucose 2.27%w/v; magnesium chloride 0.015%w/v; sodium lactate 0.39%w/v; calcium chloride 0.026%w/v
Swedish: Storbritannien natriumklorid 0.57%w/v; glukos 2.27%w/v; magnesiumklorid 0.015%w/v; natriumlaktat 0.39%w/v; kalciumklorid 0.026%w/v
English: 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
Swedish: 2,27 % w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v Peritonealdialysvätsk a
English: 22.7 g/l glucose anhydrate
Swedish: 22.7 g/l glukos anhydrat
English: Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeistof
Swedish: Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeis t of
English: Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeistof
Swedish: Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeis t of
English: Anhydrous glucose 22.7 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Swedish: Glukos anhydrat 22.7 g/L, natriumklorid 5.38 g/L, natrium -L (+) laktat 4.48 g/L, kalciumklorid dihydrat 0,184 g/L, magnesiumklorid hexahydrat 0,051 g/L
English: Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeistof
Swedish: Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeis t of